Published in Ann Oncol on April 06, 2012
Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes. J Clin Oncol (2015) 1.02
Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck. Am J Clin Oncol (2016) 0.91
Changing the paradigm: the potential for targeted therapy in laryngeal squamous cell carcinoma. Cancer Biol Med (2016) 0.91
Induction chemotherapy for locoregionally advanced head and neck cancer: past, present, future? Oncologist (2013) 0.84
Recent multidisciplinary approach with molecular targeted drugs for advanced head and neck cancer. Int J Clin Oncol (2014) 0.81
Chemoselection: a paradigm for optimization of organ preservation in locally advanced larynx cancer. Expert Rev Anticancer Ther (2013) 0.80
Small molecules in combination with conventional chemotherapeutic drugs: Light at the end of the tunnel? Oncol Lett (2012) 0.78
Is open surgery for head and neck cancers truly declining? Eur Arch Otorhinolaryngol (2013) 0.76
Organ preservation strategies: Review of literature and their applicability in developing nations. South Asian J Cancer (2014) 0.76
Role of neoadjuvant chemotherapy in advanced carcinoma of the hypopharynx and larynx. South Asian J Cancer (2017) 0.75
Hypopharyngeal squamous cell carcinoma: Three-dimensional or Intensity-modulated radiotherapy? A single institution's experience. Laryngoscope (2015) 0.75
Hypopharyngeal cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol (2016) 0.75
Salvage surgery for locoregional recurrences of advanced pharyngolaryngeal squamous cell carcinoma after organ preservation failure. Acta Otorhinolaryngol Ital (2014) 0.75
[Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma]. Strahlenther Onkol (2013) 0.75
Retrospective analysis of the clinical efficacy of definitive chemoradiotherapy for patients with hypopharyngeal cancer. Jpn J Clin Oncol (2016) 0.75
Single-cycle induction chemotherapy for resectable advanced hypopharyngeal cancer. Int J Clin Oncol (2017) 0.75
Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma. Head Neck (2017) 0.75
Pyriform sinus squamous cell carcinoma: oncological outcomes in good responders of induction chemotherapy-based larynx preservation protocols. Eur Arch Otorhinolaryngol (2014) 0.75
Matched-pair analysis of patients with advanced hypopharyngeal cancer: surgery versus concomitant chemoradiotherapy. Int J Clin Oncol (2017) 0.75
Induction chemotherapy-based larynx preservation program for locally advanced hypopharyngeal cancer: oncologic and functional outcomes and prognostic factors. Eur Arch Otorhinolaryngol (2016) 0.75
Application of xenogenic acellular dermal matrix in reconstruction of oncological hypopharyngeal defects. Eur Arch Otorhinolaryngol (2016) 0.75
Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep (1966) 48.83
Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics (1975) 18.25
Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med (2003) 13.99
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol (2011) 7.46
Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol (2007) 4.73
Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst (1996) 4.22
Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys (2006) 3.79
Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst (2009) 2.98
Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer Inst (2009) 2.83
Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck. Cancer Treat Rep (1982) 1.31
How to establish equivalence when data are censored: a randomized trial of treatments for B non-Hodgkin lymphoma. Stat Med (1993) 1.01
Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx. Head Neck (2011) 1.00
Cis-platinum and 5-fluorouracil as induction therapy for advanced head and neck cancer. Am J Surg (1982) 0.86
Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med (1997) 8.72
Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med (2001) 4.72
Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst (1996) 4.22
Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet (2005) 3.77
Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis (1999) 3.39
Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer Inst (2009) 2.83
Accelerated radiation therapy in the treatment of very advanced and inoperable head and neck cancers. Int J Radiat Oncol Biol Phys (1994) 2.46
Molecular analysis of NOZZLE, a gene involved in pattern formation and early sporogenesis during sex organ development in Arabidopsis thaliana. Proc Natl Acad Sci U S A (1999) 2.35
Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group. J Clin Oncol (1997) 2.29
Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol (1997) 2.23
Prognostic significance of radial margins of clearance in rectal cancer. Br J Surg (1996) 2.15
Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer. Eur J Cancer (1997) 2.04
Multicentre analysis of oncological and survival outcomes following anastomotic leakage after rectal cancer surgery. Br J Surg (2009) 2.00
Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer (1993) 1.90
Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC). Br J Cancer (2000) 1.84
An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group. J Infect (1998) 1.82
Endoscopic cordectomy. A proposal for a classification by the Working Committee, European Laryngological Society. Eur Arch Otorhinolaryngol (2000) 1.76
Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours. Eur J Cancer (2005) 1.75
An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis. Clin Infect Dis (1998) 1.63
Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) -- results of a phase-III multicenter clinical trial. Eur Radiol (2001) 1.60
The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. Radiother Oncol (2000) 1.53
A review on re-irradiation for recurrent and second primary head and neck cancer. Oral Oncol (2004) 1.52
Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. J Clin Oncol (1998) 1.52
[Electrochemotherapy, a new antitumor treatment: first clinical trial]. C R Acad Sci III (1991) 1.52
Lymph node prognostic factors in head and neck squamous cell carcinomas. Am J Surg (1994) 1.51
Variations in tumour oxygen tension (pO2) during accelerated radiotherapy of head and neck carcinoma. Eur J Cancer (1998) 1.49
A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. J Exp Med (1997) 1.47
Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks. Int J Radiat Oncol Biol Phys (1996) 1.46
[Prophylactic cranial irradiation in patients with extensive disease caused by small-cell lung cancer responsive to chemotherapy: fewer symptomatic brain metastases and improved survival]. Ned Tijdschr Geneeskd (2008) 1.43
Open partial horizontal laryngectomies: a proposal for classification by the working committee on nomenclature of the European Laryngological Society. Eur Arch Otorhinolaryngol (2014) 1.42
Does hyperbaric oxygen therapy improve quality of life? Int J Oral Maxillofac Surg (2008) 1.41
Zinc supplementation increases growth and circulating insulin-like growth factor I (IGF-I) in growth-retarded Vietnamese children. Am J Clin Nutr (1996) 1.36
Surgical management of carcinoma of the hypopharynx and cervical esophagus: analysis of 209 cases. Arch Surg (2001) 1.35
Phase III trial of satraplatin, an oral platinum plus prednisone vs. prednisone alone in patients with hormone-refractory prostate cancer. Oncology (2005) 1.34
Adenoid cystic carcinoma of the head and neck: evaluation with MR imaging and clinical-pathologic correlation in 27 patients. Radiology (1992) 1.34
Small cell neuroendocrine carcinoma of the nasal cavity and paranasal sinuses. J Laryngol Otol (2006) 1.33
Antitumor electrochemotherapy: new advances in the clinical protocol. Cancer (1996) 1.30
Multiple synchronous and metachronous cancers of the upper aerodigestive tract: a nine-year study. Laryngoscope (1989) 1.28
Caregiver burden in HIV-positive and HIV-negative partners of men with AIDS. J Consult Clin Psychol (1994) 1.27
Differences between gay men in primary relationships and single men: implications for prevention. AIDS Educ Prev (1996) 1.26
Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? Eur J Cancer (2003) 1.22
Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancer. Ann Oncol (2009) 1.19
Validation of the methods of cosmetic assessment after breast-conserving therapy in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer. Int J Radiat Oncol Biol Phys (1999) 1.18
Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol (1998) 1.18
What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question? Eur J Cancer (2012) 1.17
A plasmid of Rhizobium meliloti 41 encodes catabolism of two compounds from root exudate of Calystegium sepium. J Bacteriol (1988) 1.16
A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992). Ann Oncol (2008) 1.14
Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy. Br J Cancer (2013) 1.14
Quality control of radical prostatectomy: a feasibility study. Eur J Cancer (2001) 1.13
Coping and mood during aids-related caregiving and bereavement. Ann Behav Med (1996) 1.12
Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis. Br J Cancer (1996) 1.11
Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma. Neurology (2002) 1.11
Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys (2008) 1.10
Aesthesioneuroblastoma. J Laryngol Otol (1998) 1.09
Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer. Eur J Cancer (2002) 1.09
Are bisexually identified men in San Francisco a common vector for spreading HIV infection to women? Am J Public Health (1994) 1.09
The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer. Int J Radiat Oncol Biol Phys (1999) 1.08
Postbereavement depressive mood and its prebereavement predictors in HIV+ and HIV- gay men. J Pers Soc Psychol (1996) 1.07
Antiemetic effect of subhypnotic doses of propofol after thyroidectomy. Br J Anaesth (1996) 1.07
Postoperative irradiation for thyroid cancer. Eur J Surg Oncol (1993) 1.06
Characterisation of novel defective thiopurine S-methyltransferase allelic variants. Biochem Pharmacol (2008) 1.05
Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas. Histopathology (2008) 1.05
Relationship between laryngoceles and laryngeal carcinomas. Laryngoscope (1978) 1.03
Parapharyngeal metastases from thyroid cancer. Eur J Surg Oncol (2004) 1.01
ATP, bradykinin, TRH and TSH activate the Ca(2+)-phosphatidylinositol cascade of human thyrocytes in primary culture. Mol Cell Endocrinol (1991) 1.00
Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European population. Br J Pharmacol (1998) 1.00
Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948). Br J Cancer (2005) 0.99
Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma. Ann Oncol (2009) 0.99
Surgical management of surgery and radiation induced peristomal neck ulcerations. B-ENT (2008) 0.98
Positive surgical margins in neck dissection specimens in patients with head and neck squamous cell carcinoma and the effect of radiotherapy. Head Neck (2000) 0.98
Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy. Eur J Cancer (2012) 0.96
The prognostic significance of p16 overexpression in oropharyngeal squamous cell carcinoma: implications for treatment strategies and future clinical studies. Ann Oncol (2010) 0.96
Very accelerated radiation therapy: preliminary results in locally unresectable head and neck carcinomas. Int J Radiat Oncol Biol Phys (1995) 0.96
Variation in treatment and outcome of patients with rectal cancer by region, hospital type and volume in the Netherlands. Eur J Surg Oncol (2010) 0.96
Clinical aspects of early and late hypocalcaemia afterthyroid surgery. Eur J Surg Oncol (2000) 0.95
Changes in the oxygenation of head and neck tumors during carbogen breathing. Radiother Oncol (1993) 0.95
Predictive assays of radiation response in patients with head and neck squamous cell carcinoma: a review of the Institute Gustave Roussy experience. Int J Radiat Oncol Biol Phys (1997) 0.95
CT and MR imaging of squamous cell carcinoma of the tongue and floor of the mouth. Radiographics (1996) 0.95
Do results of the EORTC dummy run predict quality of radiotherapy delivered within multicentre clinical trials? Eur J Cancer (2012) 0.95
Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides. Tissue Antigens (1998) 0.95
Modes of invasion of cancer of the larynx. A statistical, histological, and radioclinical analysis of 120 cases. Cancer (1976) 0.95
A prospective longitudinal study on radiation-induced hearing loss. Am J Surg (1994) 0.94
Reconstruction with free jejunal autograft after circumferential pharyngolaryngectomy: eighty-three cases. Ann Otol Rhinol Laryngol (1998) 0.93
The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial. Cancer Radiother (2008) 0.93
Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991. Eur J Cancer (2009) 0.93
Analysis of p53 serum antibodies in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst (1996) 0.92
Tumor vascularization, mitotic index, histopathologic grade, and DNA ploidy in the assessment of 114 head and neck squamous cell carcinomas. Cancer (1995) 0.92
Adenosine triphosphate, bradykinin, and thyrotropin-releasing hormone regulate the intracellular Ca2+ concentration and the 45Ca2+ efflux of human thyrocytes in primary culture. J Cell Physiol (1989) 0.92
[Elements of completeness and results of the first year of registration of the "Registre général des cancers de Lille et de sa région"]. Rev Epidemiol Sante Publique (2012) 0.92